Stock vs Stock Comparison

McKesson Corporation vs Abbott Laboratories

MCK wins the Tale of the Tape 7–1.

MCK$739.53
ABT$86.99

🏆 Tale of the Tape

71
MCKABT
0.9%Profitability (Net Margin)14.7%
19.3xValuation (P/E)24.0x
27.0%Efficiency (ROIC)10.1%
5/9Health (Piotroski F)5/9
6.1Safety (Altman Z)4.9
16.2%Growth (Rev YoY)5.7%
0.87Risk (Sharpe 1Y)-1.05
-45.36xBalance Sheet (D/E)0.64x
4.95%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.255
252-Day Correlation
0.296
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricMCKABT
Market Cap$89.2B$149.1B
P/E Ratio19.3x24.0x
Forward P/E14.8x14.1x
P/B-41.02x2.86x
Dividend Yield0.44%2.94%
Beta0.350.65

Quantitative Metrics

MetricMCKABT
DCF Fair Value$632.61$57.20
DCF Upside-26.8%-43.2%
Piotroski F5/95/9
Altman Z6.054.87
Beneish M-2.44-2.53
FCF Yield4.95%4.21%
Net Debt/EBITDA-0.2x0.1x
ROIC27.0%10.1%
WACC7.8%9.4%
ROIC – WACC19.1pp0.7pp
Gross Margin3.7%56.4%
Net Margin0.9%14.7%
Rev Growth YoY16.2%5.7%
Sharpe (1Y)0.87-1.05
Max Drawdown 3Y-23.9%
FCF Payout Ratio7%56%

MCK Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

MCK found in:

IYK3.95%
XLV1.75%
VHT1.63%
XHS1.47%
ONEV0.82%
ONEO0.65%
QUS0.53%
MGV0.50%
SCHG0.46%
VIG0.45%
VFMV0.44%
DGRW0.42%
VTV0.39%
IWF0.36%
SPYV0.33%
VONG0.30%
ESGV0.22%
VFMO0.21%
RSP0.20%
SCHX0.20%
SCHB0.18%
VFVA0.18%
IVV0.17%
SPLG0.17%
VOO0.16%
ITOT0.15%
VONE0.15%
SPY0.15%
URTH0.14%
VTI0.14%
SPTM0.13%
ACWI0.11%
VT0.09%
IWD0.03%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

MCK vs ABT: Head-to-Head Analysis

McKesson Corporation (MCK) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, MCK leads 7–1 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, MCK generates a return on invested capital (ROIC) of 27.0% compared to ABT's 10.1%. This suggests MCK is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between MCK and ABT is 0.255, indicating low correlation, making them an effective diversification pair in a portfolio context.

MCK appears in 34 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, MCK or ABT?

Our quantitative analysis compares MCK and ABT across nine fundamental dimensions. MCK wins the Tale of the Tape 7–1. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are MCK and ABT correlated?

The 252-day correlation between MCK and ABT is 0.255. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.